Advertisement

Advertisement

CNTB Stock Latest News

Buy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway

RatingsBuy Rating on CNTB Driven by Rademikibart’s Rapid Lung Function Gains, COPD Differentiation, and Strengthened Cash Runway

Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity

PremiumRatings

Buy Rating on CNTB: Fast-Acting Rademikibart Data Underscore Differentiation and Long-Term Respiratory Opportunity

17h ago

Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results

PremiumCompany Announcements

Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results

2d ago

Connect Biopharma announces results from rademikibart study

PremiumThe Fly

Connect Biopharma announces results from rademikibart study

2d ago

CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

CNTB Earnings Report this Week: Is It a Buy, Ahead of Earnings?

8d ago

Connect Biopharma highlights new mechanism of action data for rademikibart

PremiumThe FlyConnect Biopharma highlights new mechanism of action data for rademikibart

3M ago

H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma

The Fly

H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma

3M ago

Connect Biopharma announces board resignation amid U.S. transition

Company Announcements

Connect Biopharma announces board resignation amid U.S. transition

3M ago

Connect Biopharma initiated with a Buy at Lake Street

PremiumThe Fly

Connect Biopharma initiated with a Buy at Lake Street

4M ago

Connect Biopharma Reports Significant Loss Amid Development Efforts

PremiumCompany Announcements

Connect Biopharma Reports Significant Loss Amid Development Efforts

4M ago

Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships

PremiumRatings

Promising Outlook for Connect Biopharma Holdings Driven by Rademikibart’s Potential and Strategic Partnerships

5M ago

Buy Rating for Connect Biopharma Holdings: Rademikibart’s Market Differentiation and Safety Advantages

PremiumRatings

Buy Rating for Connect Biopharma Holdings: Rademikibart’s Market Differentiation and Safety Advantages

5M ago

Connect Biopharma reports Q3 EPS (31c), consensus (24c)

PremiumThe FlyConnect Biopharma reports Q3 EPS (31c), consensus (24c)

5M ago

Promising Outlook for Connect Biopharma Holdings: Rademikibart’s Potential in Asthma and COPD

Ratings

Promising Outlook for Connect Biopharma Holdings: Rademikibart’s Potential in Asthma and COPD

5M ago

Connect Biopharma initiated with a Buy at BTIG

The Fly

Connect Biopharma initiated with a Buy at BTIG

5M ago

Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart

PremiumRatings

Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart

6M ago

Connect Biopharma presents data on rademikibart at ERS Congress

PremiumThe Fly

Connect Biopharma presents data on rademikibart at ERS Congress

6M ago

Connect Biopharma Executives Increase Share Holdings

PremiumCompany Announcements

Connect Biopharma Executives Increase Share Holdings

7M ago

Connect Biopharma management to meet virtually with Northland

PremiumThe Fly

Connect Biopharma management to meet virtually with Northland

7M ago

Connect Biopharma completes termination of ADR program, lists on Nasdaq

PremiumThe FlyConnect Biopharma completes termination of ADR program, lists on Nasdaq

7M ago

Connect Biopharma Advances Clinical Trials and Nasdaq Listing

Company Announcements

Connect Biopharma Advances Clinical Trials and Nasdaq Listing

7M ago

Connect Biopharma patners with Ickey Woods, Jovante Woods Foundation

The Fly

Connect Biopharma patners with Ickey Woods, Jovante Woods Foundation

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >